Singular Genomics Systems, Inc. 4 SEC Filings

Filed On	Filing
27 Feb 2025	Form 4: Tang Kevin, 10% owner and 2 others Returned 372,000 shares to the issuer
25 Feb 2025	Form 4: Spaventa Andrew, Director Returned 143,310 shares to the issuer · Disposed of 91,769 Stock Option (Right to Buy) (Disposition to Issuer) · Disposed of 27,248 Restricted Stock Unit (Disposition to Issuer) ($545K)
25 Feb 2025	Form 4: Meeter Dalen, Chief Financial Officer Returned 9,502 shares to the issuer · Disposed of 15,414 Stock Option (Right to Buy) (Disposition to Issuer) · Disposed of 7,874 Restricted Stock Unit (Disposition to Issuer) ($157K)
25 Feb 2025	Form 4: Glezer Eli N., Chief Scientific Officer Returned 155,583 shares to the issuer · Disposed of 24,665 Stock Option (Right to Buy) (Disposition to Issuer) · Disposed of 8,250 Restricted Stock Unit (Disposition to Issuer) ($165K)
25 Feb 2025	Form 4: Ghai Jyotsna, Chief Operating Officer Returned 3,283 shares to the issuer · Disposed of 13,333 Stock Option (Right to Buy) (Disposition to Issuer) ($123K) · Disposed of 7,583 Restricted Stock Unit (Disposition to Issuer) ($152K)
25 Feb 2025	Form 4: Ryan Jason, Director Disposed of 7,806 Stock Option (Right to Buy) (Disposition to Issuer)
25 Feb 2025	Form 4: Pellini Michael J, Director Returned 351,222 shares to the issuer · Disposed of 9,665 Stock Option (Right to Buy) (Disposition to Issuer)
25 Feb 2025	Form 4: Mardis Elaine R, Director Disposed of 6,907 Stock Option (Right to Buy) (Disposition to Issuer)
25 Feb 2025	Form 4: Kamdar Kim P., Director Returned 3,793,985 shares to the issuer · Disposed of 7,139 Stock Option (Right to Buy) (Disposition to Issuer)
25 Feb 2025	Form 4: Eisenberg Marcia, Director Disposed of 6,783 Stock Option (Right to Buy) (Disposition to Issuer)
25 Feb 2025	Form 4: Barker David L, Director Returned 1,060,000 shares to the issuer · Disposed of 7,139 Stock Option (Right to Buy) (Disposition to Issuer)
14 Feb 2025	Form 4: Spaventa Andrew, Director Received 1,907 shares by exercise or conversion · Sold 800 shares ($15.9K) · Gave 1,107 shares as a gift · 1 more
11 Feb 2025	Form 4: Meeter Dalen, Chief Financial Officer Received 500 shares by exercise or conversion
11 Feb 2025	Form 4: Glezer Eli N., Chief Scientific Officer Received 500 shares by exercise or conversion
11 Feb 2025	Form 4: Ghai Jyotsna, Chief Operating Officer Received 250 shares by exercise or conversion
06 Jan 2025	Form 4: Ghai Jyotsna, Chief Operating Officer Received 417 shares by exercise or conversion
17 Dec 2024	Form 4: Spaventa Andrew, Director Received 486 shares by exercise or conversion · Sold 180 shares ($3.63K) · Gave 306 shares as a gift · 1 more
17 Dec 2024	Form 4: Meeter Dalen, Chief Financial Officer Received 209 shares by exercise or conversion
17 Dec 2024	Form 4: Glezer Eli N., Chief Scientific Officer Received 250 shares by exercise or conversion
13 Nov 2024	Form 4: Spaventa Andrew, Director Received 1,907 shares by exercise or conversion · Sold 695 shares ($15.7K) · Gave 1,212 shares as a gift · 1 more

Comments